🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial was to assess the efficacy and safety of aeroso...
Status
Completed
Location
Banner Health
Start Date
2019-03-26
Trial ID
NCT03656926
Treatments Being Tested
The main purpose of this study is to investigate whether dupilumab is effec...
Status
Completed
Location
Regeneron study Site
Start Date
2020-10-28
Trial ID
NCT04206553
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, Pha...
Status
Recruiting
Location
Denver Arthritis Clinic - Lowry- Site Number : 8400001
Start Date
2026-05-12
Trial ID
NCT07286214
In small initial studies, combined kidney and bone marrow transplants from ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-12
Trial ID
NCT00801632
Patients who undergo a kidney transplant require prolonged therapy with dru...
Status
Completed
Location
California Institute Of Renal Research
Start Date
2015-12-31
Trial ID
NCT02137239
Primary Objective: To investigate the efficacy of the standard dose of Thy...
Status
Completed
Location
CHINA
Start Date
2017-08-16
Trial ID
NCT03099122
This protocol corresponds to an open-label national phase II, multicenter, ...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2011-07
Trial ID
NCT01376401
Treatments Being Tested
The purpose of the study is to evaluate the safety and efficacy of Tocilizu...
Status
Active Not Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-07-09
Trial ID
NCT06452537
Treatments Being Tested
The purpose of the proposed study is to determine whether the addition of i...
Status
Terminated
Location
Erie County Medical Center
Start Date
2016-01
Trial ID
NCT02499887
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241